These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32833143)

  • 41. Patient experiences with oily skin: the qualitative development of content for two new patient reported outcome questionnaires.
    Arbuckle R; Atkinson MJ; Clark M; Abetz L; Lohs J; Kuhagen I; Harness J; Draelos Z; Thiboutot D; Blume-Peytavi U; Copley-Merriman K
    Health Qual Life Outcomes; 2008 Oct; 6():80. PubMed ID: 18925946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary Ciliary Dyskinesia: First Health-related Quality-of-Life Measures for Pediatric Patients.
    Dell SD; Leigh MW; Lucas JS; Ferkol TW; Knowles MR; Alpern A; Behan L; Morris AM; Hogg C; DunnGalvin A; Quittner AL
    Ann Am Thorac Soc; 2016 Oct; 13(10):1726-1735. PubMed ID: 27464304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.
    Horodniceanu EG; Bal V; Dhatt H; Carter JA; Huang V; Lasch K
    Health Qual Life Outcomes; 2017 Jun; 15(1):129. PubMed ID: 28645270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement tools.
    Arbuckle R; Humphrey L; Abraham L; Dennerstein L; Simon JA; Mirkin S; Bonner N; Walmsley S; Tatlock S; Symonds T
    Maturitas; 2014 Jul; 78(3):219-27. PubMed ID: 24856282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and content validation of the Multifactoral assessment of perceived social support (MAPSS), a brief, patient-reported measure of social support for use in HIV care.
    Fredericksen RJ; Fitzsimmons E; Gibbons LE; Dougherty S; Loo S; Shurbaji S; Batey DS; Avendano-Soto S; Mathews WC; Christopoulos K; Mayer KH; Mugavero MJ; Crane PK; Crane HM
    AIDS Care; 2019; 31(sup1):1-9. PubMed ID: 31189333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
    J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2-The Patient Assessment for Low Back Pain-Impacts (PAL-I).
    Bushnell DM; Blum SI; Liedgens H; Martin ML; Freynhagen R; Wallace M; Argoff C; Eerdekens M; Kok M; Patrick DL
    Pain; 2018 Oct; 159(10):2066-2075. PubMed ID: 29889120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS).
    Foley C; Tundia N; Simpson E; Teixeira HD; Litcher-Kelly L; Bodhani A
    Curr Med Res Opin; 2019 Jul; 35(7):1139-1148. PubMed ID: 30561230
    [No Abstract]   [Full Text] [Related]  

  • 49. Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.
    Jacobson TA; Edelman SV; Galipeau N; Shields AL; Mallya UG; Koren A; Davidson MH
    Patient; 2017 Jun; 10(3):321-334. PubMed ID: 27981439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The TBI-CareQOL Measurement System: Development and Preliminary Validation of Health-Related Quality of Life Measures for Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury.
    Carlozzi NE; Kallen MA; Hanks R; Hahn EA; Brickell TA; Lange RT; French LM; Kratz AL; Tulsky DS; Cella D; Miner JA; Ianni PA; Sander AM
    Arch Phys Med Rehabil; 2019 Apr; 100(4S):S1-S12. PubMed ID: 30195987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and Psychometric Evaluation of an Instrument Assessing Barriers to Growth Hormone Treatment (BAR-GHT).
    de Zwaan M; Fischer-Jacobs J; Wabitsch M; Reinehr T; Meckes-Ferber S; Crosby RD
    Front Endocrinol (Lausanne); 2020; 11():84. PubMed ID: 32158432
    [No Abstract]   [Full Text] [Related]  

  • 52. Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD).
    Globe G; Currie B; Leidy NK; Jones P; Mannino D; Martinez F; Klekotka P; O'Quinn S; Karlsson N; Wiklund I
    Health Qual Life Outcomes; 2016 Jul; 14(1):104. PubMed ID: 27424173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and Validation of the AFImpact: An Atrial Fibrillation-Specific Measure of Patient-Reported Health-Related Quality of Life.
    Coyne KS; Edvardsson N; Rydén A
    Value Health; 2017 Dec; 20(10):1355-1361. PubMed ID: 29241895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measuring the impact of burn scarring on health-related quality of life: Development and preliminary content validation of the Brisbane Burn Scar Impact Profile (BBSIP) for children and adults.
    Tyack Z; Ziviani J; Kimble R; Plaza A; Jones A; Cuttle L; Simons M
    Burns; 2015 Nov; 41(7):1405-19. PubMed ID: 26421693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a patient-reported experience questionnaire for patients with sarcoma: the Sarcoma Assessment Measure (SAM).
    Martins A; Bennister L; Fern LA; Gerrand C; Onasanya M; Storey L; Wells M; Whelan JS; Windsor R; Woodford J; Taylor RM
    Qual Life Res; 2020 Aug; 29(8):2287-2297. PubMed ID: 32227293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelines.
    Moore P; Jackson C; Mutch K; Methley A; Pollard C; Hamid S; Jacob A
    BMJ Open; 2016 Sep; 6(9):e011142. PubMed ID: 27694484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
    Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
    Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating functional outcomes in adolescents with attention-deficit/hyperactivity disorder: development and initial testing of a self-report instrument.
    Hareendran A; Setyawan J; Pokrzywinski R; Steenrod A; Madhoo M; Erder MH
    Health Qual Life Outcomes; 2015 Aug; 13():133. PubMed ID: 26297205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and validation of the Parenteral Nutrition Impact Questionnaire (PNIQ), a patient-centric outcome measure for Home Parenteral Nutrition.
    Wilburn J; McKenna SP; Heaney A; Rouse M; Taylor M; Culkin A; Gabe S; Burden S; Lal S
    Clin Nutr; 2018 Jun; 37(3):978-983. PubMed ID: 28446383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.